JPMorgan analyst Jessica Fye upgraded BioNTech (NASDAQ: BNTX) from Underweight to Neutral with a price target of $125.00 (from $91.00).The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE